Functional Chewing Gum in Reduction of Gingival Inflammation

Gingivitis Clinical Trial

Official title:

Use of a Functional Chewing Gum in Reduction of Gingival Inflammation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03237624
• Other study ID #: HP-00073354
• Status: Completed
• Phase: N/A
• Start date: January 31, 2018
• Est. completion date: January 31, 2020

Study information

• Verified date: March 2020
• Source: University of Maryland, Baltimore
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this prospective randomized 3-month double-blinded single center study is to determine whether a chewing gum device with food additive chitosan, will aid in reducing gingival inflammation by supplementing traditional tooth brushing and flossing measures. Patients with mild to moderate gingivitis will be identified and enrolled in this investigation. All enrolled subjects will receive baseline oral hygiene brushing instructions and a baseline clinical examination of the gingiva. The test group will utilize the test chewing gum three times a day for a minimum 20-30 minutes duration; the control group will receive a placebo gum and use it in a similar manner. We will examine whether daily use of a functional chewing gum enhances improvements to brushing and flossing.

Description:

Periodontal disease remains a prevalent and preventable disease in man. Plaque bacterial biofilm remains the primary etiologic agent of disease; colonization of non-shedding tooth surfaces greatly contributes to initiation and progression of gingivitis, for example. Although there are currently available chemotherapeutic agents to supplement daily oral hygiene measures, one continuous issue is patient compliance. Chewing gum represents a unique delivery device for not only drugs and other agents, but food additives that might aid in reducing bacteria plaque colonization on tooth surfaces. For example, chitosan and chitosan-related food additive preparations have been shown to have some antimicrobial-like properties, possibly in the disruption of bacterial colonization (not -cidal).

NOTE: ALL INGREDIENTS of the "test" chewing gum, and the placebo chewing gum, are generally regarded as safe ("GRAS" label by the Food and Drug Administration), as they are common food components. For example, chitosan is listed in the GRAS database (https://www.accessdata.fda.gov/scripts/fdcc/?set=SCOGS). See item GRN No. 397.

This study aims to determine whether adjunctive use of functional chewing gum will improve gingival inflammation status—retaining clinical gains initiated by professional tooth cleaning and at home brushing over a 12 week period in gingivitis patients.

Eligibility criteria and outcome measures are described in the next section.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: January 31, 2020
• Est. primary completion date: January 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Mild-moderate gingivitis

• Minimum of 20 natural teeth

Exclusion Criteria:

• Significant alveolar bone loss as evidenced by Bite-wings (>3.0 mm cementoenamel junction to bone)

• Requirement for antibiotic pre-medication prior to dental procedures

• Systemic antibiotic use in past 14 days to current.

• Use of oral contraceptives

• Use of anti-inflammatory (NSAIDs) or in past 14 days.

• Use of anticoagulant therapy or in past 14 days.

• Poorly controlled diabetes (HbA1c > 7.9%)*

• Smoking

• Pregnancy

• Use of any oral rinses such as, but not limited to chlorhexidine, essential oils, cetylpyridinium chloride during the study.

Related Conditions & MeSH terms

• Gingivitis
• Inflammation

Intervention

Device:
• Functional Chitosan Chewing Gum
Chitosan and chitosan-related preparations have been shown to have some antimicrobial properties, possibly in the disruption of bacterial colonization. It is thought that as a component of a functional chewing gum this will supplement in the removal of daily build up of dental plaque on tooth surfaces.
• Control Chewing Gum
Control chewing gum device does not have food additive chitosan in its composition.

Behavioral:
• Oral hygiene measures
Patients will be given instructions on how to brush and floss routinely (twice per day)

Locations

Country	Name	City	State
United States	University of Maryland School of Dentistry	Baltimore	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
University of Maryland, Baltimore

Country where clinical trial is conducted

United States, 

References & Publications (4)

Kaur S, Dhillon GS. The versatile biopolymer chitosan: potential sources, evaluation of extraction methods and applications. Crit Rev Microbiol. 2014 May;40(2):155-75. doi: 10.3109/1040841X.2013.770385. Epub 2013 Mar 14. Review. — View Citation

Li Y, Lee S, Hujoel P, Su M, Zhang W, Kim J, Zhang YP, DeVizio W. Prevalence and severity of gingivitis in American adults. Am J Dent. 2010 Feb;23(1):9-13. — View Citation

Machul A, Mikolajczyk D, Regiel-Futyra A, Heczko PB, Strus M, Arruebo M, Stochel G, Kyziol A. Study on inhibitory activity of chitosan-based materials against biofilm producing Pseudomonas aeruginosa strains. J Biomater Appl. 2015 Sep;30(3):269-78. doi: 10.1177/0885328215578781. Epub 2015 Apr 8. — View Citation

Simons D, Beighton D, Kidd EA, Collier FI. The effect of xylitol and chlorhexidine acetate/xylitol chewing gums on plaque accumulation and gingival inflammation. J Clin Periodontol. 1999 Jun;26(6):388-91. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Gum inflammation change	Measure the color of gingiva - use Gingiva Index	Change in color of gingiva from baseline to 12 weeks
Secondary	Plaque levels (on teeth) change	Measure plaque using Plaque Index	Change in plaque level from baseline to 12 weeks